Mild weight loss reduces inflammatory cytokines, leukocyte count, and oxidative stress in overweight and moderately obese participants treated for 3 years with dietary modification

Nutrition Research

Volumn 33, Issue 3, 2013, Pages 195-203

  Chae, Jey Sook ^a   Paik, Jean Kyung ^a   Kang, Ryungwoo ^a   Kim, Minjoo ^a   Choi, Yongin ^a   Lee, Sang Hyun ^b   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b National Health Insurance Corporation   (South Korea)

Author keywords

Diet induced, long term, mild weight reduction; Leukocyte count; Overweight obese; Oxidative stress; Proinflammatory cytokines

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; CHOLESTEROL; CYTOKINE; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY FAT; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIET THERAPY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; PROTEIN BLOOD LEVEL; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOSITY; ADULT; BODY MASS INDEX; CYTOKINES; DIET, REDUCING; DINOPROST; FEMALE; HUMANS; INFLAMMATION; INSULIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTE COUNT; LIPIDS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84875380949     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2013.01.005     Document Type: Article

References (44)

1. Strohacker K., McFarlin B.K. Influence of obesity, physical inactivity, and weight cycling on chronic inflammation. Front Biosci 2010, 2:98-104.
2. Vincent H.K., Taylor A.G. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes 2006, 30:400-418.
3. Musaad S., Haynes E.N. Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev 2007, 29:98-114.
4. Shin M.J., Jang Y., Koh S.J., Chae J.S., Kim O.Y., Lee J.E., Ordovas J.M., Lee J.H. The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss. Int J Obes 2006, 30:1702-1708.
5. Shin M.J., Hyun Y.J., Kim O.Y., Kim J.Y., Jang Y., Lee J.H. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes 2006, 30:1529-1534.
6. Jang Y., Kim O.Y., Lee J.H., Koh S.J., Chae J.S., Kim J.Y., Park S., Cho H., Lee J.E., Ordovas J.M. Genetic variation at the perilipin locus is associated with changes in serum free fatty acids and abdominal fat following mild weight loss. Int J Obes 2006, 30:1601-1608.
7. Morel O., Luca F., Grunebaum L., Jesel L., Meyer N., Desprez D., Robert S., Dignat-George F., Toti F., Simon C., Goichot B. Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. Int J Obes (Lond) 2011, 35:1479-1486.
8. Gugliucci A., Kotani K., Taing J., Matsuoka Y., Sano Y., Yoshimura M., Egawa K., Horikawa C., Kitagawa Y., Kiso Y., Kimura S., Sakane N. Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults. Ann Nutr Metab 2009, 54:197-201.
9. Brook R.D., Bard R.L., Glazewski L., Kehrer C., Bodary P.F., Eitzman D.L., Rajagopalan S. Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. Am J Cardiol 2004, 93:1012-1016.
10. Finley P.R., Schifman R.B., Williams R.J., Lichti D.A. Cholesterol in high-density lipoprotein: use of Mg2+506/dextran sulfate in its enzymic measurement. Clin Chem 1978, 24:931-933.
11. Lekarski Pol Merkur Evaluation of the precision of the Friedewald's formula for the calculation of low density lipoprotein cholesterol concentration in serum. Pol Merkur Lekarski 2001, 11:348-351.
12. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
13. Ohira S., Kirk A.B., Dasgupta P.K. Automated measurement of urinary creatinine by multichannel kinetic spectrophotometry. Anal Biochem 2009, 384:238-244.
14. Kopelman P. Health risks associated with overweight and obesity. Obes Rev 2007, 8(Suppl 1):13-17.
15. Heymsfield S.B., Harp J.B., Reitman M.L., Beetsch J.W., Schoeller D.A., Erondu N., Pietrobelli A. Why do obese patients not lose more weight when treated with low-calorie diets? A Mechanistic perspective. Am J Clin Nutr 2007, 85:346-354.
16. Basu S. Bioactive eicosanoids: role of prostaglandin F2α and F2-isoprostanes in inflammation and oxidative stress related pathology. Mol Cells 2010, 30:383-391.
17. Keaney J.F., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., Benjamin E.J. Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003, 23:434-439.
18. Helmersson J., Vessby B., Larsson A., Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004, 109:1729-1734.
19. Davì G., Guagnano M.T., Ciabattoni G., Basili S., Falco A., Marinopiccoli M., Nutini M., Sensi S., Patrono C. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002, 288:2008-2014.
20. Shoelson S.E., Lee J., Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 2003, 27:S49-S52.
21. Singh U., Devaraj S., Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2003, 25:151-174.
22. Federico A., Morgillo F., Tuccillo C., Ciardiello F., Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007, 121:2381-2386.
23. Pou K.M., Massaro J.M., Hoffmann U., Vasan R.S., Maurovich-Horvat P., Larson M.G., Keaney J.F., Meigs J.B., Lipinska I., Kathiresan S., Murabito J.M., O'Donnell C.J., Benjamin E.J., Fox C.S. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007, 116:1234-1241.
24. Dinarello C.A. The biological properties of interleukin-1. Eur Cytokine Netw 1994, 5:517-531.
25. Marx N., Neumann F.J., Ott I., Gawaz M., Koch W., Pinkau T., Schömig A. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 1997, 30:165-170.
26. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem J 1990, 265:621-636.
27. Bruunsgaard H., Pedersen M., Pedersen B.K. Aging and proinflammatory cytokines. Curr Opin Hematol 2001, 8:131-136.
28. Kim O.Y., Chae J.S., Paik J.K., Seo H.S., Jang Y., Cavaillon J.M., Lee J.H. Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. Age 2012, 34:415-425.
29. Wannamethee S.G., Whincup P.H., Rumley A., Lowe G.D. Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost 2007, 5:1637-1643.
30. Sekitani Y., Hayashida N., Kadota K., Yamasaki H., Abiru N., Nakazato M., Maeda T., Ozono Y., Takamura N. White blood cell count and cardiovascular biomarkers of atherosclerosis. Biomarkers 2010, 15:454-460.
31. Lao X.Q., Neil Thomas G., Jiang C., Zhang W., Adab P., Lam T.H., Cheng K.K. White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank Cohort Study. Atherosclerosis 2008, 201:418-424.
32. Li C., Engström G., Hedblad B. Leukocyte count is associated with incidence of coronary events, but not with stroke: a prospective cohort study. Atherosclerosis 2010, 209:545-550.
33. Friedman G.D., Fireman B.H. The leukocyte count and cancer mortality. Am J Epidemiol 1991, 133:376-380.
34. Grimm R.H., Neaton J.D., Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985, 254:1932-1937.
35. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., Ricart W. Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001, 86:1154-1159.
36. Vincent M.A., Montagnani M., Quon M.J. Molecular and physiologic actions of insulin related to produ 576 ction of nitric oxide in vascular endothelium. Curr Diab Rep 2003, 3:279-288.
37. Koh K.K. Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovasc Res 2002, 55:714-726.
38. Saito I., Yonemasu K., Inami F. Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. Circ J 2003, 67:323-329.
39. Esposito K., Pontillo A., Di Palo C., Giugliano G., Masella M., Marfella R., Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289:1799-1804.
40. Cartier A., Lemieux I., Alméras N., Tremblay A., Bergeron J., Després J.P. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab 2008, 93:1931-1938.
41. Kirwan J.P., Krishnan R.K., Weaver J.A., Del Aguila L.F., Evans W.J. Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia. Am J Physiol Endocrinol Metab 2001, 281:E1137-E1143.
42. González F., Minium J., Rote N.S., Kirwan J.P. Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia. Metabolism 2006, 55:271-276.
43. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998, 98:1487-1494.
44. Hulthe J., Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 2002, 22:1162-1167.